This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Jake Jacobs, MPA; Anita Das, MS
Center for Economic Studies in Medicine Reston, Va

JAMA. 1990;263(24):3260-3261.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

The article on the risk of hip fracture by Ray et al¹ raises several questions worthy of further discussion. The abstract and, especially, the press coverage given the study suggest that hip fractures in patients who receive long-acting benzodiazepine are a major public health problem. Approximately 211 000 hip fractures occur in elderly Americans annually.² Study results indicate that, at most, 5.8% of hip fractures occurred in patients who received long-acting benzodiazepines, while 20.6% occurred in patients who received other psychotropic drugs. We are interested in seeing the point prevalence of long-acting benzodiazepine and other psychotropic use in the entire elderly population in Saskatchewan, Canada. We would not be surprised to see that benzodiazepine use is comparable with that among study case subjects, while the use of other psychotropics is far lower than that among study case subjects.

A more important issue is that the . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?